Sipai Health Technology Co., Ltd. (HKG:0314)
Hong Kong · Delayed Price · Currency is HKD 1.430
0.00 (0.00%)
Apr 24, 2026, 4:08 PM HKT
Sipai Health Technology Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,071 | 4,565 | 4,712 | 4,119 | 3,474 | |
Revenue Growth (YoY) | -54.64% | -3.11% | 14.39% | 18.58% | 28.68% |
Cost of Revenue | 1,761 | 4,180 | 4,300 | 3,786 | 3,193 |
Gross Profit | 310.2 | 385.53 | 412.45 | 333.97 | 281.06 |
Selling, General & Admin | 394.75 | 602.32 | 640.11 | 907.86 | 961.48 |
Research & Development | 10.2 | 22.26 | 45.95 | 62.65 | 59.21 |
Other Operating Expenses | 11.17 | - | - | - | 0.66 |
Operating Expenses | 425.78 | 659.88 | 696.02 | 975.98 | 1,028 |
Operating Income | -115.58 | -274.35 | -283.57 | -642.01 | -746.69 |
Interest Expense | -1.43 | -3.07 | -3.49 | -4.04 | -3.69 |
Interest & Investment Income | 8.29 | 15.82 | 31.34 | 17.25 | 10.37 |
Earnings From Equity Investments | -0.06 | -0.19 | -0.41 | 0.33 | 0.14 |
Currency Exchange Gain (Loss) | -3.56 | - | -0.03 | 0.01 | 3.95 |
Other Non Operating Income (Expenses) | 3.32 | -54.11 | 24.34 | -759.7 | -3,038 |
EBT Excluding Unusual Items | -109.02 | -315.89 | -231.82 | -1,388 | -3,774 |
Merger & Restructuring Charges | -17.93 | -22.3 | - | - | - |
Impairment of Goodwill | -4.79 | -34.1 | -31.28 | - | - |
Gain (Loss) on Sale of Investments | 15.52 | 17.52 | 17.45 | 22.36 | 25.66 |
Gain (Loss) on Sale of Assets | -12.53 | -1.77 | -1 | -0.7 | -0.08 |
Asset Writedown | - | -5.03 | - | - | - |
Other Unusual Items | 0.59 | 0.92 | 0.98 | -1.93 | 0.37 |
Pretax Income | -128.16 | -360.64 | -245.67 | -1,368 | -3,748 |
Income Tax Expense | -1.38 | 1.19 | 1.04 | 3.32 | 0.83 |
Earnings From Continuing Operations | -126.78 | -361.83 | -246.71 | -1,372 | -3,749 |
Minority Interest in Earnings | 2.51 | 38.1 | -9.06 | 1.19 | 8.05 |
Net Income | -124.27 | -323.74 | -255.77 | -1,371 | -3,740 |
Net Income to Common | -124.27 | -323.74 | -255.77 | -1,371 | -3,740 |
Shares Outstanding (Basic) | 602 | 639 | 644 | 112 | 99 |
Shares Outstanding (Diluted) | 602 | 639 | 644 | 112 | 99 |
Shares Change (YoY) | -5.79% | -0.78% | 472.64% | 13.10% | -0.55% |
EPS (Basic) | -0.21 | -0.51 | -0.40 | -12.19 | -37.61 |
EPS (Diluted) | -0.21 | -0.51 | -0.40 | -12.19 | -37.61 |
Free Cash Flow | - | -67.91 | -138.86 | -186.02 | -638.5 |
Free Cash Flow Per Share | - | -0.11 | -0.22 | -1.65 | -6.42 |
Gross Margin | 14.98% | 8.44% | 8.75% | 8.11% | 8.09% |
Operating Margin | -5.58% | -6.01% | -6.02% | -15.58% | -21.49% |
Profit Margin | -6.00% | -7.09% | -5.43% | -33.27% | -107.67% |
Free Cash Flow Margin | - | -1.49% | -2.95% | -4.52% | -18.38% |
EBITDA | -100.75 | -259.52 | -267.49 | -626.62 | -726.84 |
EBITDA Margin | -4.87% | -5.68% | -5.68% | -15.21% | -20.92% |
D&A For EBITDA | 14.83 | 14.83 | 16.08 | 15.39 | 19.85 |
EBIT | -115.58 | -274.35 | -283.57 | -642.01 | -746.69 |
EBIT Margin | -5.58% | -6.01% | -6.02% | -15.58% | -21.49% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.